Rob Surgical Systems
Designs and develops new robotic systems for minimally invasive surgery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
* | €5.0m | Seed | |
| Total Funding | 000k | ||
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (113380 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 113897 % | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Rob Surgical specializes in developing cutting-edge robotic systems designed for minimally invasive surgery. The company's flagship product, the Bitrack system, aims to universalize high-precision surgery by providing advanced technological solutions that improve surgical outcomes. Rob Surgical primarily serves healthcare providers, including hospitals and surgical centers, operating in the medical technology market. The business model revolves around the sale and maintenance of its robotic systems, generating revenue through direct sales, service contracts, and potential future upgrades. The company recently secured a 5 million euros investment round with Scranton, highlighting investor confidence in its innovative approach and market potential.
Keywords: robotic surgery, minimally invasive, Bitrack system, high-precision, healthcare technology, surgical outcomes, medical innovation, investment, healthcare providers, advanced technology.